Searched for
SOLIFENACIN SUCCINATE
Glenmark, Sun Pharma, Zydus recall products in USGlenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, according to the ...- Stocks in the news: RIL, ICICI Bank, L&T, Yes Bank, Tata Motors and ITCKotak Bank, L&T, Axis Bank, Tata Motors, SBI Life , Vedanta, DLF, GSK Pharma, Coromandel International and Navin Fluorin will announce quar...
- Cipla recalls 7,228 bottles of overactive bladder treatment drug in AmericaAs per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...
- Zydus Cadila gets USFDA nod for overactive bladder treatment drugThe company has received final approval from the United States Food and Drug Administration (USFDA) to market Solifenacin Succinate tablets...
- Strides Pharma suspends sale of Ranitidine tab in USIn a regulatory filing, the company said it has received an Information Request from the USFDA to provide test data related to NDMA impurit...
- Strides Pharma Science arm gets USFDA nod for drug to treat overactive bladderThe approved product is a generic version of Vesicare tablets of Astellas Pharma US, Inc.
- Alembic Pharma gets USFDA nod for overactive bladder treatment drugThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the stren...
- Zydus Cadila gets USFDA nod for two drugsThe group has also received the tentative approval for Solifenacin Succinate tablets in strengths of 5 mg and 10 mg, Zydus Cadila said.
- Glenmark Pharma's overactive bladder drug gets USFDA nodAccording to IMS Health April 2017 sales data, the market for Vesicare tablets, 5 mg and 10 mg, saw annual sales of approximately USD 1.1 b...
Load More
